Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Return on Invested Capital: 2012-2025

Historic Return on Invested Capital for Ani Pharmaceuticals (ANIP) over the last 7 years, with Sep 2025 value amounting to 0.07%.

  • Ani Pharmaceuticals' Return on Invested Capital was N/A to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07%, marking a year-over-year change of. This contributed to the annual value of 0.00% for FY2024, which is 6.00% down from last year.
  • Per Ani Pharmaceuticals' latest filing, its Return on Invested Capital stood at 0.07% for Q3 2025, which was up 418.38% from 0.01% recorded in Q2 2025.
  • Over the past 5 years, Ani Pharmaceuticals' Return on Invested Capital peaked at 0.07% during Q3 2025, and registered a low of -0.07% during Q1 2022.
  • Its 3-year average for Return on Invested Capital is 0.03%, with a median of 0.01% in 2025.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first dropped by 6bps in 2022, then rose by 10bps in 2023.
  • Over the past 5 years, Ani Pharmaceuticals' Return on Invested Capital (Quarterly) stood at -0.06% in 2021, then climbed by 2bps to -0.04% in 2022, then increased by 10bps to 0.06% in 2023, then decreased by 6bps to 0.00% in 2024, then reached 0.07% in 2025.
  • Its last three reported values are 0.07% in Q3 2025, 0.01% for Q2 2025, and 0.00% during Q4 2024.